Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer.

Andrew J. Armstrong,Jun Luo,David M. Nanus,Paraskevi Giannakakou,Russell Z. Szmulewitz,Daniel C. Danila,Patrick Healy,Monika Anand,William R. Berry,Tian Zhang,Michael R. Harrison,Changxue Lu,Yan Chen,Giuseppe Galletti,Joseph Daniel Schonhoft,Howard I. Scher,Richard Wenstrup,Scott T. Tagawa,Emmanuel S. Antonarakis,Daniel J. George,Susan Halabi

Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer.

2020

PURPOSEAndrogen receptor splice variant 7 (AR-V7) detection in circulating tumor cells (CTCs) is associated with a low probability of response and short progression-free (PFS) and overall survival ...

Keywords:

multicenter study
Prostate cancer
castration resistant
Internal medicine
Circulating tumor cell
Taxane
Hormone
Medicine
Oncology
Receptor
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations